Tom McKillop: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
== Tom McKillop == | |||
[[File:RBS_Fleet_Street.jpg|thumb|right|The Royal Bank of Scotland's office on Fleet Street, London]] | |||
Sir Thomas Fulton Wilson McKillop, commonly known as Tom McKillop, is a prominent figure in the field of [[pharmaceuticals]] and [[banking]]. He is best known for his role as the former CEO of [[AstraZeneca]] and as the chairman of the [[Royal Bank of Scotland Group]]. | |||
McKillop | |||
=== | === Early Life and Education === | ||
Tom McKillop was born in 1943 in [[Ayrshire]], [[Scotland]]. He pursued his higher education at the [[University of Glasgow]], where he earned a degree in [[chemistry]]. He later completed a [[PhD]] in [[organic chemistry]] at the same institution. | |||
== | === Career in Pharmaceuticals === | ||
McKillop | McKillop began his career in the pharmaceutical industry with [[ICI Pharmaceuticals]], which later became part of [[AstraZeneca]]. He played a significant role in the development of several key drugs and was instrumental in the company's growth and success. In 1999, he became the CEO of AstraZeneca, a position he held until 2005. | ||
== | === Transition to Banking === | ||
After retiring from AstraZeneca, McKillop transitioned to the banking sector. In 2005, he was appointed as the chairman of the Royal Bank of Scotland Group. His tenure at RBS was marked by significant challenges, including the financial crisis of 2008. | |||
== | === Legacy and Impact === | ||
McKillop is | Tom McKillop is recognized for his contributions to both the pharmaceutical and banking industries. His leadership at AstraZeneca helped the company become one of the leading pharmaceutical firms globally. However, his time at RBS was more controversial due to the bank's involvement in the financial crisis. | ||
== | == Related Pages == | ||
* [[AstraZeneca]] | * [[AstraZeneca]] | ||
* [[Royal Bank of Scotland]] | * [[Royal Bank of Scotland Group]] | ||
* [[ | * [[Pharmaceutical industry]] | ||
* [[Banking]] | |||
[[Category:Scottish businesspeople]] | [[Category:Scottish businesspeople]] | ||
[[Category: | [[Category:Pharmaceutical industry]] | ||
[[Category: | [[Category:Banking]] | ||
Latest revision as of 11:34, 15 February 2025
Tom McKillop[edit]
Sir Thomas Fulton Wilson McKillop, commonly known as Tom McKillop, is a prominent figure in the field of pharmaceuticals and banking. He is best known for his role as the former CEO of AstraZeneca and as the chairman of the Royal Bank of Scotland Group.
Early Life and Education[edit]
Tom McKillop was born in 1943 in Ayrshire, Scotland. He pursued his higher education at the University of Glasgow, where he earned a degree in chemistry. He later completed a PhD in organic chemistry at the same institution.
Career in Pharmaceuticals[edit]
McKillop began his career in the pharmaceutical industry with ICI Pharmaceuticals, which later became part of AstraZeneca. He played a significant role in the development of several key drugs and was instrumental in the company's growth and success. In 1999, he became the CEO of AstraZeneca, a position he held until 2005.
Transition to Banking[edit]
After retiring from AstraZeneca, McKillop transitioned to the banking sector. In 2005, he was appointed as the chairman of the Royal Bank of Scotland Group. His tenure at RBS was marked by significant challenges, including the financial crisis of 2008.
Legacy and Impact[edit]
Tom McKillop is recognized for his contributions to both the pharmaceutical and banking industries. His leadership at AstraZeneca helped the company become one of the leading pharmaceutical firms globally. However, his time at RBS was more controversial due to the bank's involvement in the financial crisis.
